“Use of Eculizumab in Atypical Hemolytic Uremic Syndrome Associated With Impaired Renal Function: Integrative Review”. Archives Health Sciences, vol. 26, no. 1, Dec. 2022, pp. 72-75, https://doi.org/10.17696/2318-3691.26.1.2019.1222.